Several analysts have recently updated their ratings and price targets for ORIC Pharmaceuticals (NASDAQ: ORIC): 4/4/2022 – ORIC Pharmaceuticals was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $10.00 price target on the stock, up previously from $7.00. 3/30/2022 – ORIC Pharmaceuticals was downgraded by […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Rating) CFO Dominic Piscitelli bought 60,000 shares of the firm’s stock in a transaction on Thursday, March 31st. The shares were acquired at an average cost of $5.36 per share, with a total value of $321,600.00. The acquisition was disclosed in a filing with the SEC, which can be […]
A number of research firms have changed their ratings and price targets for ORIC Pharmaceuticals (NASDAQ: ORIC): 3/25/2022 – ORIC Pharmaceuticals was downgraded by analysts at HC Wainwright from a “buy” rating to a “neutral” rating. 3/25/2022 – ORIC Pharmaceuticals was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Rating) – Stock analysts at Jefferies Financial Group issued their Q1 2022 earnings per share estimates for ORIC Pharmaceuticals in a research note issued on Tuesday, March 22nd. Jefferies Financial Group analyst M. Raycroft expects that the company will post earnings of ($0.58) per share for the quarter. Jefferies […]
North American Morning Briefing: Stock Futures -3- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.